Clinical trial
Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of…
NCT00493311 · Mallinckrodt, Industry · Completed
Key facts
| NCT number | NCT00493311 |
|---|---|
| Title | Safety of Intravenous Acetaminophen Vs Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study of the Efficacy and Safety of Intravenous Acetaminophen Versus Placebo for the Treatment of Endotoxin-Induced Fever in Healthy Adult Males |
| Lead sponsor | Mallinckrodt, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Fever |
| Intervention type | Biological, Drug |
| Interventions | IV Placebo, IV Acetaminophen, Reference Standard Endotoxin (RSE) |
| Enrollment | 60 |
| Start date | Jun 1, 2007 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Jun 28, 2007 |
| Last update posted | Oct 19, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: